Abstract: The present invention provides a method for trimming a resin film which can recycle lug portions of the resin film after trimming, can easily trim the resin film even when the resin film is made of resin which becomes fragile by cooling, and enhance the use efficiency of a laminated sheet by making resin coated portions disposed at both sides of the laminated sheet thin. At the time of coating molten resin at least on one surface of a substrate to form a resin film after making the molten resin pass between coating rolls, the lug portions of the resin film are trimmed before the lug portions of the resin film are cooled.

Abstract: The present invention provides a method for trimming a resin film which can recycle lug portions of the resin film after trimming, can easily trim the resin film even when the resin film is made of resin which becomes fragile by cooling, and enhance the use efficiency of a laminated sheet by making resin coated portions disposed at both sides of the laminated sheet thin. At the time of coating molten resin at least on one surface of a substrate to form a resin film after making the molten resin pass between coating rolls, the lug portions of the resin film are trimmed before the lug portions of the resin film are cooled.

Abstract: A display voltage generating circuit (2-1) for generating display voltages needed to drive an LCD has switches (SW1-1 to SW1-5), of which each has one end connected to one of capacitors (C1 to C5) for smoothing display voltages (V1 to V5) and has the other end connected through one of resistors (R11 to R15) to a supplied voltage (VCC). By an output from a timer (T-1), the switches are kept on for a predetermined period after electric power starts being supplied, so that the capacitors are charged with the supply voltage.

Abstract: The present invention provides a method for manufacturing laminated material which can remove ear portions of a resin film extruded from an extruding machine and can directly laminate the resin film to a substrate and can make the processing of end portions of a laminated material after lamination unnecessary. The present invention also provides an apparatus used for such a manufacturing method. In the method for manufacturing laminated material which laminates a resin film formed by extruding molten thermoplastic resin from a T-die to a substrate, a laminating film is formed by cutting ear portions of the resin film before lamination and the laminating film is laminated to the substrate.

Abstract: A metal member to be cast-wrapped by a metal cast article, a manufacturing method thereof and a metal cast article including the metal member cast-wrapped are provided. A hollow cylindrical metal member having an outer surface with projections to be cast-wrapped by a metal cast article is manufactured in such a manner that a hollow cylindrical metal raw material 13 is inserted in a die 17 having a inner peripheral surface with longitudinal grooves of a depth H and a width W, and the hollow cylindrical metal raw material 13 is subjected to hot-extrusion.

Abstract: An inexpensive mechanical fuse having a high fatigue limit ratio and high rupture reliability, and superior in forming performance, and a method of manufacturing the same are presented. The mechanical fuse is composed of Fe-based sintered alloy, and comprises an inner rim 2 fixed to one power transmission shaft, an outer rim 3 fixed to the other power transmission shaft, and plural arms 4 for linking the inner rim 2 and outer rim 3, which are formed integrally. The arms 4 include rupture portions 6 which are ruptured when exposed to an overload torque. By treating in steam, an iron oxide phase is formed in the surface layer and pore inner wall. The iron oxide phase is effective to form round pores and lower the notch sensitivity. As a result, the fatigue strength and fatigue limit ratio are enhanced.

Abstract: A vane type valve timing adjustment device used in an internal combustion engine, wherein a plurality of vanes are formed radially and integrally from a boss portion of a vane rotor and a stopper portion able to contact a housing side is formed at a specific vane among these. Since a large stress acts at the root portion where the specific vane connects with the boss portion, stress is prevented from concentrating at the root portion by chamfering the corner or forming a connecting part with a large radius of curvature or a nonmachined surface, surface hardened surface, etc. to increase the strength.

Abstract: A structure for mounting a bumper beam 2 extending transversely of a vehicle covered with a bumper face 6 and mounted to a chassis 3 through a support 4, in which the bumper beam 2 is formed into a hollow body made of high-tension steel, the front end of the support 4 extends forward beyond the rear portion of the bumper beam 2. Thus, when a large collision energy works on the lightweight bumper beam formed into a hollow body made of high-tension steel, the collision energy is quickly transferred to the vehicle chassis through the front end of the beam.

Abstract: A triazolo-1,4-di-azepine compound of the below given formula and a pharmacologically acceptable salt thereof are useful in the pharmaceutical field, especially in treating allergic diseases. ##STR1## in which R.sup.1 and R.sup.2 are hydrogen or an alkyl, R.sup.3 is hydrogen or a halogen, R.sup.4 is hydrogen or an alkyl, X is --OCO--, and Y is a cycloalkyl, a cycloalkylalkyl, an alkynyl or others.

Abstract: A triazolo-1,4-di-azepine compound of the below given formula and a pharmacologically acceptable salt thereof are disclosed and useful in the pharmaceutical field, especially to allergic diseases. ##STR1## in which R.sup.1 and R.sup.2 are hydrogen or an alkyl, R.sup.3 is hydrogen or a halogen, R.sup.4 is hydrogen or an alkyl, X is --OCO--, --NHCO--, --CO-- or others and Y is a cycloalkyl, a cycloalkylalkyl, an alkynyl or others.

Abstract: A triazolo-1,4-di-azepine compound of the below given formula and a pharmacologically acceptable salt thereof are disclosed and useful in the pharmaceutical field, especially to allergic diseases. ##STR1## in which R1 and R2 are hydrogen or an alkyl, R3 is hydrogen or a halogen, R4 is hydrogen or an alkyl, X is --OOO--, --NHCO--, --CO-- or others and Y is a cycloalkyl, a cycloalkylalkyl, an alkynyl or others.

Abstract: A triazolo-1,4-di-azepine compound of the below given formula and a pharmacologically acceptable salt thereof are disclosed and useful in the pharmaceutical field, especially to treat allergic diseases: ##STR1## in which R1 and R2 are hydrogen or an alkyl, R3 is hydrogen or a halogen, R4 is hydrogen or an alkyl, X is --OCO--, --NHCO--, --CO-- or others and Y is a cycloalkyl, a cycloalkylalkyl, an alkynyl or others.

Abstract: A triazolo-1,4-azepine compound of the below given formulas and a pharmacologically acceptable salt thereof are disclosed and useful in the pharmaceutical field, especially to allergic diseases. ##STR1## in which R1 and R2 are hydrogen or an alkyl, R3 is hydrogen or a halogen, R4 is hydrogen or an alkyl, X is --OCO--, --NHCO--, --CO-- or others and Y is a cycloalkyl, a cycloalkylalkyl, an alkynyl or others.

Abstract: A triazolo-1,4-di-azepine compound of the below given formula and a pharmacologically acceptable salt thereof are disclosed and useful in the pharmaceutical field, especially to allergic diseases, ##STR1## in which R.sup.1 and R.sup.2 are hydrogen or an alkyl, R.sup.3 is hydrogen or a halogen, R.sup.4 is hydrogen or an alkyl, X is --OCO--, --NHCO--, --CO-- or others and Y is a cycloalkyl, a cycloalkylalkyl, an alkynyl or others.

Abstract: A triazolo-1,4-di-azepine compound of the below given formulas and a pharmacologically acceptable salt thereof are disclosed and useful in the pharmaceutical field, especially to allergic diseases. ##STR1## in which R1 and R2 are hydrogen or an alkyl, R3 is hydrogen or a halogen, R4 is hydrogen or an alkyl, X is --OCO--, --NHCO--, --CO-- or others and Y is a cycloalkyl, a cycloalkylalkyl, an alkynyl or others.

Abstract: A quinone derivative of the formula (I): ##STR1## in which A is a group of the formula (IV): ##STR2## or a group of the formula (V): ##STR3## in which X and Y are either the same as or different from each other and each are hydroxy, methoxy or hydrogen; and n is an integer of 1 to 5,is disclosed. The compound is useful as a medicament.

Abstract: A novel compound, 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid, and a salt thereof are disclosed together with a number of different processes for the preparation of the compound. The uses of the novel compound as an agent for treating papillomata are also disclosed.

Abstract: Skin diseases with keratinization and allergic or inflammatory skin diseases are treated by orally or parenterally administering to an adult human patient from 40 mg to 4 g/day of a polyprenyl compound having the formula (I): ##STR1## in which each of n and m is 0, 1, or 2, n+m is 0, 1 or 2, A is ##STR2## and B is ##STR3## [in which R represents the hydroxyl group, a lower alkoxy group, or ##STR4## (wherein each of R.sub.1 and R.sub.

Abstract: A novel compound, 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid, and a salt thereof are disclosed together with a number of different processes for the preparation of the compound. The uses of the novel compound as an anticancer agent are also disclosed.

Abstract: An anti-cancer agent which comprises a polyprenvl compound having the formula (I): ##STR1## in which each of n and m is 0, 1 or 2, n+m is 0, 1 or 2, A is ##STR2## and B is ##STR3## in which R represents the hydroxyl group, a lower alkoxy group, or ##STR4## (wherein each of R.sub.1 and R.sub.